DK2103608T3 - Helicobacter pylori eradikerende middel med inhiberende virkning på mavesyresekretion - Google Patents

Helicobacter pylori eradikerende middel med inhiberende virkning på mavesyresekretion

Info

Publication number
DK2103608T3
DK2103608T3 DK07849849.0T DK07849849T DK2103608T3 DK 2103608 T3 DK2103608 T3 DK 2103608T3 DK 07849849 T DK07849849 T DK 07849849T DK 2103608 T3 DK2103608 T3 DK 2103608T3
Authority
DK
Denmark
Prior art keywords
eradictive
medicinal
helicobacter pylori
acid secretion
inhibitive effects
Prior art date
Application number
DK07849849.0T
Other languages
English (en)
Inventor
Masaharu Ito
Masaichi Yamamoto
Original Assignee
Arigen Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arigen Pharmaceuticals Inc filed Critical Arigen Pharmaceuticals Inc
Application granted granted Critical
Publication of DK2103608T3 publication Critical patent/DK2103608T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK07849849.0T 2006-12-18 2007-12-18 Helicobacter pylori eradikerende middel med inhiberende virkning på mavesyresekretion DK2103608T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006340323 2006-12-18
PCT/JP2007/001419 WO2008075462A1 (ja) 2006-12-18 2007-12-18 胃酸分泌抑制作用を併せ持つヘリコバクター・ピロリ除菌剤

Publications (1)

Publication Number Publication Date
DK2103608T3 true DK2103608T3 (da) 2012-09-17

Family

ID=39536102

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07849849.0T DK2103608T3 (da) 2006-12-18 2007-12-18 Helicobacter pylori eradikerende middel med inhiberende virkning på mavesyresekretion

Country Status (17)

Country Link
US (1) US8778975B2 (da)
EP (1) EP2103608B1 (da)
JP (1) JP5097126B2 (da)
KR (1) KR101283682B1 (da)
CN (1) CN101553480B (da)
AU (1) AU2007335663B2 (da)
BR (1) BRPI0720539A2 (da)
CA (1) CA2671949C (da)
DK (1) DK2103608T3 (da)
ES (1) ES2390611T3 (da)
HK (1) HK1131149A1 (da)
MX (1) MX2009006638A (da)
PL (1) PL2103608T3 (da)
PT (1) PT2103608E (da)
RU (1) RU2451682C2 (da)
SI (1) SI2103608T1 (da)
WO (1) WO2008075462A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010116740A1 (ja) 2009-04-09 2010-10-14 アリジェン製薬株式会社 ピリジンチオ誘導体及びそれを含有する抗ヘリコバクター・ピロリ作用を有する医薬組成物
CN110003176B (zh) * 2019-05-28 2021-12-21 沈阳药科大学 含有酰胺的苯并咪唑类化合物及其应用
CN110003177B (zh) * 2019-05-28 2021-11-19 沈阳药科大学 含有脲基的苯并咪唑类化合物及应用
JOP20220220A1 (ar) 2020-03-13 2023-01-30 Janssen Biotech Inc مواد وطرق لربط لكتين شبيه بالجوبيولين المناعي بحمض سياليك
US20220411504A1 (en) 2020-05-27 2022-12-29 Janssen Biotech, Inc. Proteins comprising cd3 antigen binding domains and uses thereof
AR125210A1 (es) 2021-03-24 2023-06-21 Janssen Biotech Inc Anticuerpos dirigidos a cd22 y cd79b
KR20230160353A (ko) 2021-03-24 2023-11-23 얀센 바이오테크 인코포레이티드 Cd3 항원 결합 도메인을 포함하는 단백질 및 이의 용도
WO2023046322A1 (en) 2021-09-24 2023-03-30 Janssen Pharmaceutica Nv Proteins comprising cd20 binding domains, and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL66340A (en) 1981-08-13 1986-08-31 Haessle Ab Pharmaceutical compositions comprising pyridylmethyl-thiobenzimidazole derivatives,certain such novel derivatives and their preparation
SE8300736D0 (sv) 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
JPS6150979A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
FI90544C (fi) 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
JP2694361B2 (ja) 1989-02-09 1997-12-24 アストラ アクチエボラグ 抗菌剤
JPH0720865B2 (ja) 1989-02-10 1995-03-08 武田薬品工業株式会社 抗菌剤
JPH0348680A (ja) 1989-07-18 1991-03-01 Yoshitomi Pharmaceut Ind Ltd 抗菌剤
JP2798588B2 (ja) 1992-08-21 1998-09-17 エーザイ株式会社 抗菌剤
HUT76639A (en) * 1994-07-20 1997-10-28 Byk Gulden Lomberg Chem Fab Pyridyl-thio-compounds, process for producing them and their use
ES2171116B1 (es) * 2000-04-14 2003-08-01 Esteve Quimica Sa Procedimiento para la obtencion de derivados de (((piridil sustituido)metil)tio)bencimidazol.
WO2003082854A1 (fr) * 2002-03-29 2003-10-09 Zeria Pharmaceutical Co., Ltd. Derives 1-n-aminobenzimidazole

Also Published As

Publication number Publication date
CN101553480A (zh) 2009-10-07
EP2103608A1 (en) 2009-09-23
PT2103608E (pt) 2012-09-24
SI2103608T1 (sl) 2012-12-31
WO2008075462A1 (ja) 2008-06-26
MX2009006638A (es) 2009-07-02
KR101283682B1 (ko) 2013-07-08
RU2451682C2 (ru) 2012-05-27
JP5097126B2 (ja) 2012-12-12
US20100173944A1 (en) 2010-07-08
AU2007335663A1 (en) 2008-06-26
RU2009127750A (ru) 2011-01-27
CN101553480B (zh) 2013-06-05
PL2103608T3 (pl) 2013-02-28
KR20090101890A (ko) 2009-09-29
HK1131149A1 (en) 2010-01-15
CA2671949A1 (en) 2008-06-26
ES2390611T3 (es) 2012-11-14
EP2103608A4 (en) 2010-12-22
US8778975B2 (en) 2014-07-15
JPWO2008075462A1 (ja) 2010-04-08
EP2103608B1 (en) 2012-08-29
AU2007335663B2 (en) 2011-12-15
CA2671949C (en) 2011-11-01
BRPI0720539A2 (pt) 2014-01-07

Similar Documents

Publication Publication Date Title
DK2103608T3 (da) Helicobacter pylori eradikerende middel med inhiberende virkning på mavesyresekretion
NL300871I2 (nl) ixazomib en farmaceutisch aanvaardbare zouten en esters daarvan, zoals ixazomibcitraat
DK2328601T3 (da) Linaclotid-holdige formuleringer til oral indgivelse
DK2001903T3 (da) Langtidsvirkende polypeptider og fremgangsmåder til fremstilling og administration deraf
DK3092901T3 (da) Quinolonanaloger og fremgangsmåder relateret dertil
DK2077729T3 (da) Orale probiotiske doseringsformer
DK2152078T3 (da) Formuleringer indeholdende clopidogrel og sulfoalkylethercyclodextrin og anvendelsesfremgangsmåder
DK1919458T3 (da) Syreresistent cysteamin, cystamin og derivater deraf
BRPI0820861A2 (pt) Comprimido oral dispersível
DK2185164T3 (da) Sammensætning og terapeutisk antitumorvaccine
DK2099434T3 (da) Indretninger og systemer til medikamentindgivelse
ATE516044T1 (de) Attenuierte rotavirus-vakzine zur oralen verabreichung
BRPI0810439A2 (pt) Formulações farmacêuticas contendo derivados de ácido lipóico
EP2135074A4 (en) PHARMACEUTICAL PLATFORM TECHNOLOGY FOR THE DEVELOPMENT OF NATURAL PRODUCTS
BRPI0719394A2 (pt) Preparação medicinal sólida
DK2313404T3 (da) Quinuclidin-carbonat-derivater og medicinsk sammensætning deraf
DK2432456T3 (da) Faste farmaceutiske sammensætninger og fremgangsmåder til fremstilling deraf
DK2114393T3 (da) Farmaceutiske sammensætninger omfattende trigonellin og 4-hydroxyisoleucin og fremgangsmåde hertil
NO20060919L (no) Boyle til barnestol
FI20061029A0 (fi) Hammashoitolaitteisto
NO20073252L (no) Fremgangsmate for kontinuerlig og proporsjonal kalktilsetting
GB0717567D0 (en) Track and hold circuit
FI20061024A0 (fi) Hammashoitolaitteisto
IL198160A0 (en) Pharmaceutical formulations
ZA200806949B (en) Medicinal formulation for the treatment for hepatitis C